O'Malley seeks increase in state stem cell funding
A new look into cancer's roots
In the high-stakes world of stem cell research, success or failure can hinge on the turn of a phrase; it sall about Word Choices
Romney's 'flip-flops' not what they seem
Md. cannot afford to lag in stem cell research race
Research unbound
Applications filed for stem cell funding
Stem cells without drawbacks?
Journal is advised to check for fraud
Christianity and stem cells
Playing the Nazi card
Cardin and Steele face the nation
Celebrities lend faces to ads in higher campaign profile
Stem cell experiment killed embryos, researchers say
Stem cell method preserves embryos
Edge from a wedge
Osiris shares hold up in IPO
Osiris bucks trend with today's IPO
Leaving stem cell politics behind
A chance for achievement
Researchers eager for stem cell funding
SATURDAY MAILBOX
Stop animal testing - it's not just cruel, it's ineffective
UM medical school dean named
Plan would create lines of human stem cells
Biotech Osiris to try IPO again
Korea indicts cloning researcher
Capital Notebook
Stem cell bill nears vote in Md. House
Senate passes stem cell bill
On the floor, talk ran on and on
LETTERS TO THE EDITOR
Senate prepares for filibuster
Stem cell advances
Stem cell bill limits rejected
Stem cell debate hits home
Stem cell bill gains
Stem cell research accord sought
Steele's words at meeting faulted
Stem cell program described
GOP senators vow to filibuster stem cell research measure
Churches' views vary on stem cells
Hold scientists accountable
THE WEEK THAT WAS
Ehrlich science adviser retracts statement on research funding
From cells arises Osiris Company was started four years ago in new area of medicine; Groundbreaking discovery; Firm has gained powerful ally with Novartis investment
Osiris joins efforts with drug giant Novartis, local firm to collaborate on bone treatments; Gene therapies for tissue; Baltimore would get manufacturing plant for approved products